Did you know?

ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.  

Learn more >>

Free Newsletter

Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!

  Email address:
   

Recent Articles in Cell & Gene Therapy

Belief BioMed Starts China Registrational Trial of Gene Therapy for Hemophilia A
MediLink Signs $1 Billion ADC Out-Licensing Rights Agreement with Roche
Qilu In-Licenses siRNA Targeting PCSK9 from Ribo in $100 Million Agreement
Innovent And Sanegene Collaborate to Develop siRNA for Hypertension
Biocytogen and CtM Biotech Identify Tri-Specific T Cell Engager for Cancers
ChinaBio® News

Greg Scott BIO-Europe Interview
Greg Scott Interviewed at BIO-Europe Spring

How to bring your China assets to China in 8 minutes


Greg Scott Mendelspod Interview
"Mr. Bio in China."
Mendelspod Interview

Multinational pharma held to a higher standard in China

Partner Event
November 2-3, 2023 | Shanghai
November 7-8, 2023 | Digital